Monday, April 21, 2014, North Hollywood, CA--The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – applauds Kentucky Gov. Steve Beshear for signing HB 126 (The Cancer Treatment Modernization Act) into law. The bill requires health plans regulated by the state that provide coverage for IV and oral anticancer treatments- to not exceed $100 copayment or coinsurance for a 30-day supply of orally administered anticancer treatment.
“It’s encouraging to see states recognize that policy needs to keep pace with medical advances that offer lifelines to patients who have exhausted other treatments,” said Susie Novis, President and Co-founder of the IMF. “On behalf of cancer patients, the IMF is passionately engaged in raising awareness of this discrepancy in health care coverage in legislatures across the nation. We are grateful to Kentucky State Sen- Tom Buford (R-Nicholasville) for his swift action and commitment to passing this bill this year. He is a true champion of the cancer community.”
“After years of high out-of-pocket expenses and an inability to afford the most effective therapies, cancer patients in Kentucky, will finally have access to lifesaving, cutting-edge oral anticancer medications,” said Zina Cary, National State Affairs Consultant for the IMF.
Advocate Toni O'Neil, who testified on behalf of the legislation in March, said, "I am so pleased that Gov. Beshear signed this bill as it will enable my son to return to Kentucky to live and work without fear of impossibly high co-pays." O’Neil’s son, who has multiple myeloma and will be on an oral anticancer treatment for the foreseeable future, currently lives in New York, where a similar law was passed in 2011.
Kentucky joins 30 other states and the District of Columbia in passing similar legislation, bringing the total to 31 states and DC, with similar laws.
ABOUT THE INTERNATIONAL MYELOMA FOUNDATION
Celebrating its 23rd anniversary, the International Myeloma Foundation reaches more than 350,000 members in 120 countries worldwide. A 501 (c) 3 non-profit organization dedicated to improving the quality of life of myeloma patients and their families, the IMF focuses on four key areas: research, education, support, and advocacy. To date, the IMF has conducted more than 250 educational seminars worldwide, maintains a world-renowned hotline, and established the International Myeloma Working Group (IMWG), a collaborative research initiative focused on improving myeloma treatment options for patients. The IMF can be reached at (800) 452-CURE (2873). The global website is www.myeloma.org. Follow the IMF on Twitter at @IMFmyeloma.
Zina Cary, National State Affairs Consultant